Zusammenfassung
Der Gastrointestinaltrakt stellt mit 100–400 m2 die weitaus größte Oberfläche dar, mit der der Körper mit der Außenwelt in Kontakt steht. Im Darmlumen befinden sich zahlreiche Mikroorganismen und Substanzen, die für den Körper Fremdstoffe (Antigene) darstellen. Die Aufnahme dieser Antigene kann für den Menschen deletäre Folgen haben. Die Mukosa im Gastrointestinaltrakt muß deshalb über sehr effektive Mechanismen verfügen, um den Organismus vor dem Eindringen dieser Fremdstoffe zu schützen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Allan CH, Mendrich DL, Trier JS (1993) Rat intestinal M cells contain acidic endosomal-lysosomal compartments and express class II major histocompatibility complex determinants. Gastroenterology 104: 698–708
Bland PW, Warren LG (1986) Antigen presentation by epithelial cells of the rat small intestine. II. Selective induction of suppressor T cells. Immunology 58: 9–14
Blumberg RS, Terhorst C, Bleicher P et al. (1991) Expression of a nonpolymorphic MHC class I-like molekule, CD1d, by human intestinal epithelial cells. J Immunol 147: 2518–2524
Boughton-Smith NK (1995) Nitrix oxide in ulcerative colitis and Crohn’s disease. In: Tytgat GNJ, Bartelsman JFWM, van Deventer SJH (eds) Inflammatory bowel disease. Kluwer Academic Publishers, Dordrecht Boston London, pp 90–100
Boussiotis VA, Freeman GJ, Gribben JG, Nadler LM (1996) The role of B7-l/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down regulation of the immune response. Immunol Rev 153: 5–26
Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84: 2068–2101
Casini RV, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F (1995) Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 154: 2434–2440
Conley ME, Delacroix DL (1987) Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? Ann Intern Med 106: 892–899
Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Büschenfelde K-H (1995) Tolerance exists towards intestinal flora but is broken in active inflammatory bowel diesease (IBD). Clin Exp Immunol 102: 448–455
Fuss IJ, Neurath M, Boirivant M (1996) Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157: 1261–1270
Gemsa D, Resch K (1997) Entzündung. In: Gemsa D, Kalden JR, Resch K (Hrsg) Immunologie, 4. Aufl. Thieme, Stuttgart New York, S 135–158
Gross V, Arndt H, Andus T, Palitzsch KD, Schölmerich J (1994) Free radicals in inflammatory bowel diseases patho-physiology and therapeutic implications. Hepatogastroenterology 41: 320–327
Hermiston ML, Gordon JI (1995) Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270: 1203–1207
Janeway CA, Travers P (1995) Immunologie. Spektrum Akademischer Verlag, Heidelberg Berlin Oxford
Kaetzel CS, Robinson JK, Chintalacharuvu KR, Vaerman JP, Lamm ME (1991) The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA. Proc Natl Acad Sci USA 88: 8796–8800
Kerneis S, Bogdanova A, Colucci GE, Kraehenbuhl JP, Pringault E (1996) Cytosolic distribution of villin in M cells from mouse Peyer’s patches correlates with the absence of a brush border. Gastroenterology 110: 515–521
Kerneis S, Bogdanova A, Kraehenbuhl J-P, Pringault E (1997) Conversion by Peyer’s Patch Lymphocytes of Human Enterocytes into M cells that transport bacteria. Science 277: 949–952
Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263–274
Mahida YR, Wu KC, Jewell DP (1989) Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut 30: 1362–1370
Marth T, Strober W, Kelsall BL (1996) High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol 157: 2348–2357
Mayer L, Eisenhardt D (1990) Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease. J Clin Invest 86: 1255–1260
Mayer L, Shlien R (1987) Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med 166: 1471–1483
Mochizuki K, Hayashi N, Katayama K et al. (1997) B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C. Hepatology 25: 713–718
Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145–173
Owen RL, Pierce NF, Apple RT, Croy WCJ (1986) M cell transport of Vibrio cholerae from the intestinal lumen into Peyer’s patches: a mechanism for antigen sampling and for microbial transepithelial migration. J Infect Dis 153: 1108–1118
Pirzer U, Schonhaar A, Fleischer B, Hermann E, Meyer zum Buschenfelde, K.-H. (1991) Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn’s disease. Lancet 338: 1238–1239
Qiao L, Schurmann G, Betzler M, Meuer SC (1991) Activation and signaling status of human lamina propria T lymphocytes. Gastroenterology 101: 1529–1536
Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253–261
Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedler A (1995) Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 108: 21–33
Strobel S, Mowat AM, Ferguson A (1985) Prevention of oral tolerance induction to ovalbumin and enhanced antigen presentation during a graft-versus-host reaction in mice. Immunology 56: 57–64
Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath M (1997) Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18: 61–64
Weiner HL, Friedman A, Miller A et al. (1994) Oral tolerance: Immunologic mechanisms and treatment of autoantigens. Annu Rev Immunol 12: 809–837
Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H (1993) Intestinal permeability and the prediction of relapse in Crohn’s disease. Lancet 341: 1437–1439
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stallmach, A., Zeitz, M. (2000). Das Immunsystem im Gastrointestinaltrakt — Mechanismen der Entzündung. In: Adler, G., Beglinger, C., Manns, M.P., Müller-Lissner, S., Schmiegel, W. (eds) Klinische Gastroenterologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57194-7_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-57194-7_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-65059-1
Online ISBN: 978-3-642-57194-7
eBook Packages: Springer Book Archive